What's new on Contemporary Pediatrics: October 26 to October 30
A look at what to expect from Contemporary Pediatrics this week.
A report examines the effect of blood transfusions administered before neonatal surgery on the postoperative outcomes.
A look at whether breastfeeding offers children protection from infections and how long that protection could last.
Plus, a commentary from Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN on the impact of COVID-19 on children with attention-deficit/hyperactivity disorder.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
FDA approves concizumab-mtci for hemophilia A/B without inhibitors in patients 12 years and older
August 4th 2025The FDA approved concizumab-mtci (Alhemo; Novo Nordisk) for hemophilia A/B without inhibitors, offering once-daily subcutaneous prophylaxis that significantly reduces bleeding rates.
